US Stock MarketDetailed Quotes
PRE Prenetics Global
- 3.1900
- +0.0400+1.27%
Close Apr 18 16:00 ET
38.93MMarket Cap-571P/E (TTM)
3.3230High3.1400Low71.12KVolume3.2400Open3.1500Pre Close229.94KTurnover0.88%Turnover RatioLossP/E (Static)12.21MShares15.900052wk High0.19P/B25.65MFloat Cap3.135052wk Low--Dividend TTM8.04MShs Float131.2500Historical High--Div YieldTTM5.81%Amplitude3.1400Historical Low3.2330Avg Price1Lot Size
About Prenetics Global Company
Prenetics Global Ltd. is a genomics-driven health sciences company, which engages in the prevention, early detection, and treatment of diseases. It operates through the Prevention and Diagnostic segments. The Prevention segment is involved in the design and sale of genetics testing and stool-based DNA tests for early colorectal cancer screening. The Diagnostic segment consists of COVID-19 testing services and products, and precision oncology services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.
Company Profile
SymbolPRE
Company NamePrenetics Global
Listing DateJul 16, 2021
Founded2014
CEOMr. Danny Sheng Wu Yeung
MarketNASDAQ
Employees400
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressK11 Atelier King's Road,728 King's Road, Unit 703-706,Quarry Bay
CityHong Kong，China
ProvinceHK
CountryChina
Phone852-2210-9588
Websitehttp://www.prenetics.com
Company Executives
- Name
- Position
- Salary
- Danny Sheng Wu Yeung
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Yung Ho Peter Wong
- Chief Technology Officer
- --
- Dr. Shih-Chang Frank Ong
- Chief Medical Officer
- --
- Dr. Senthil Sundaram
- Chief Clinical Officer
- --
- Hoi Chun Stephen Lo
- Chief Financial Officer
- --
- Chi Hung Lawrence Tzang
- Chief Scientific Officer
- --
- Dr. Zhanfeng Cui
- Director
- --
- Yin Pan Cheng
- Independent Director
- --
- Ian Ying Woo
- Independent Director
- --
- Wing Kwan Winnie Chiu
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg